Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gyula Ostoros

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Cancer Research|July 20, 2006
Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancerBalazs Dome, Jozsef Timar, Judit Dobos, et al.
Magyar Onkologia|December 15, 2015
[Excerpts from the collaborative lung cancer research program of Semmelweis University, the National Institute of Oncology and Korányi Institute of TB and Pulmonology (2010-2015)]Balázs Hegedûs, Judit Moldvay, Judit Berta, et al.
The Oncologist|March 13, 2020
Access to Novel Drugs for Non-Small Cell Lung Cancer in Central and Southeastern Europe: A Central European Cooperative Oncology Group AnalysisTanja Cufer, Tudor E Ciuleanu, Peter Berzinec, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 3, 2012
Discrimination of clinical stages in non-small cell lung cancer patients by serum HSP27 and HSP70: a multi-institutional case-control studyMatthias Zimmermann, Stefanie Nickl, Christopher Lambers, et al.
Scientific Reports|January 5, 2017
KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasisZoltan Lohinai, Thomas Klikovits, Judit Moldvay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2009
High VEGFR-3-positive circulating lymphatic/vascular endothelial progenitor cell level is associated with poor prognosis in human small cell lung cancerKrisztina Bogos, Ferenc Renyi-Vamos, Judit Dobos, et al.
Frontiers in Oncology|February 14, 2022
Chromosomal Aberrations in Blood Lymphocytes as Predictors of Respiratory Function After Stereotactic Lung IrradiationZsuzsa S Kocsis, Gyöngyi Farkas, András Bajcsay, et al.
Lung Cancer (Amsterdam, Netherlands)|June 26, 2010
Therapy of small cell lung cancer with emphasis on oral topotecanRobert Pirker, Peter Berzinec, Stephen Brincat, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 29, 2010
Apelin expression in human non-small cell lung cancer: role in angiogenesis and prognosisJudit Berta, Istvan Kenessey, Judit Dobos, et al.
European Radiology|March 5, 2022
Nationwide lung cancer screening with low-dose computed tomography: implementation and first results of the HUNCHEST screening programAnna Kerpel-Fronius, Zsuzsanna Monostori, Gabor Kovacs, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Cancer Research|July 20, 2006
Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancerBalazs Dome, Jozsef Timar, Judit Dobos, et al.
Magyar Onkologia|December 15, 2015
[Excerpts from the collaborative lung cancer research program of Semmelweis University, the National Institute of Oncology and Korányi Institute of TB and Pulmonology (2010-2015)]Balázs Hegedûs, Judit Moldvay, Judit Berta, et al.
The Oncologist|March 13, 2020
Access to Novel Drugs for Non-Small Cell Lung Cancer in Central and Southeastern Europe: A Central European Cooperative Oncology Group AnalysisTanja Cufer, Tudor E Ciuleanu, Peter Berzinec, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 3, 2012
Discrimination of clinical stages in non-small cell lung cancer patients by serum HSP27 and HSP70: a multi-institutional case-control studyMatthias Zimmermann, Stefanie Nickl, Christopher Lambers, et al.
Scientific Reports|January 5, 2017
KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasisZoltan Lohinai, Thomas Klikovits, Judit Moldvay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2009
High VEGFR-3-positive circulating lymphatic/vascular endothelial progenitor cell level is associated with poor prognosis in human small cell lung cancerKrisztina Bogos, Ferenc Renyi-Vamos, Judit Dobos, et al.
Frontiers in Oncology|February 14, 2022
Chromosomal Aberrations in Blood Lymphocytes as Predictors of Respiratory Function After Stereotactic Lung IrradiationZsuzsa S Kocsis, Gyöngyi Farkas, András Bajcsay, et al.
Lung Cancer (Amsterdam, Netherlands)|June 26, 2010
Therapy of small cell lung cancer with emphasis on oral topotecanRobert Pirker, Peter Berzinec, Stephen Brincat, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 29, 2010
Apelin expression in human non-small cell lung cancer: role in angiogenesis and prognosisJudit Berta, Istvan Kenessey, Judit Dobos, et al.
European Radiology|March 5, 2022
Nationwide lung cancer screening with low-dose computed tomography: implementation and first results of the HUNCHEST screening programAnna Kerpel-Fronius, Zsuzsanna Monostori, Gabor Kovacs, et al.
Pageof 6